Academic Journal
أعرض في EDS

The Activity of Influenza Viruses during 2017-2018 Season in Russia and Countries of the Northern Hemisphere: Conflict by the B-virus Vaccine Component ; Активность вирусов гриппа в сезон 2017-2018 гг. в России и странах Северного полушария: конфликт по В-вирусному компоненту вакцин

التفاصيل البيبلوغرافية
العنوان: The Activity of Influenza Viruses during 2017-2018 Season in Russia and Countries of the Northern Hemisphere: Conflict by the B-virus Vaccine Component ; Активность вирусов гриппа в сезон 2017-2018 гг. в России и странах Северного полушария: конфликт по В-вирусному компоненту вакцин
المؤلفون: D. Lvov K., E. Burtseva I., E. Mukasheva A., L. Kolobukhina V., S. Trushakova V., N. Breslav V., E. Feodoritova L., L. Merkulova N., K. Krasnoslobotsev G., E. Morozova O., I. Fedyakina T., A. Aristova V., R. Vartanian V., L. Kisteneva B., A. Prilipov G., S. Alkhovsky V., A. Rosatkevich G., I. Kruzhkova S., A. Belyaev L., E. Axselrod V., M. Bazarova V., S. Smetanina V., Д. Львов К., Е. Бурцева И., Е. Мукашева А., Л. Колобухина В., С. Трушакова В., Н. Бреслав В., Е. Феодоритова Л., Л. Меркулова Н., К. Краснослободцев Г., Е. Морозова О., И. Федякина Т., В. Аристова А., Р. Вартанян В., Л. Кистенева Б., А. Прилипов Г., С. Альховский В., А. Росаткевич Г., И. Кружкова С., А. Беляев Л., Э. Аксельрод В., М. Базарова В., С. Сметанина В.
المساهمون: The work was supported by the Cooperative agreement «The support of potential for influenza surveillance in Russia» with Centers for Disease Control and Prevention, Atlanta, USA, Исследование было частично поддержано Кооперативным cоглашением «Поддержание потенциала по надзору за гриппом в России» с Центрами по контролю и профилактике заболеваний, Атланта, США
المصدر: Epidemiology and Vaccinal Prevention; Том 18, № 3 (2019); 13-21 ; Эпидемиология и Вакцинопрофилактика; Том 18, № 3 (2019); 13-21 ; 2619-0494 ; 2073-3046 ; 10.31631/2073-3046-2019-18-3
بيانات النشر: «Numicom» LLC
سنة النشر: 2019
المجموعة: Epidemiology and Vaccine Prevention (E-Journal) / Эпидемиология и Вакцинопрофилактика
مصطلحات موضوعية: epidemic season 2017-2018, influenza viruses, antigenic properties, genetic properties, sensitivity to neuraminidase inhibitors, recommendations for influenza vaccines composition in the season 2019-2020, эпидемический сезон 2017-2018, вирусы гриппа, антигенные свойства, генетические свойства, чувствительность к антинейраминидазным препаратам, рекомендации по составу гриппозных вакцин в сезоне 2019-2020 гг
الوصف: Relevance. Influenza viruses, having an extremely high variability of the genome and significant environmental plasticity, continue to maintain a potential threat to the biological safety of mankind. The purpose Aims of the work is to analyze the features of the epidemic season of2017-2018.Materials and methods. The collection of data on the incidence and laboratory diagnosis of influenza and ARVI was carried out in the framework of the epidemiological surveillance of the circulation of influenza viruses in the Russian Federation. The observation period was from 40 weeks (october) 2017 to 25 weeks (june) 2018. The typing of the isolates was performed in the reaction of inhibition of hemagglutination activity (HI) according to the standard technique with diagnostic sera to reference and epidemic influenza viruses.Results and discussion. The article presents the features of the influenza virus circulation n for the period from october 2017 to may 2018 in some territories of Russia, collaborating with D. I. Ivanovsky Institute of Virology. The epidemic season had its own peculiarities: delayed and long-term activity of three influenza viruses, the share participation of which was almost equal, with some dominance of the influenza A(H1N1)pdm09 virus by the end of the season. Morbidity rates for the total population were comparable with the last epidemic season, meantime the morbidity among schoolchildren was higher. The number of hospitalizations and lethal outcomes was lower and mostly was found in patients of 65 years and older. In patients with severe acute respiratory infection (SARI) influenza A(H1N1)pdm09 was detected more frequently (58%). The influenza A(H1N1)pdm09 and A(H3N2) viruses were antigenically similar to strains included in influenza vaccines, at the same time, 96% of the isolated strains of influenza B virus belonged to a different evolutionary line. Epidemic strains were sensitive to neuraminidase inhibitors, except for 5 strains of influenza A(H1N1)pdm09 virus, isolated from pregnant ...
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: Russian
Relation: https://www.epidemvac.ru/jour/article/view/737/537; Komissarov A., Fadeev A., Petrov S., et al. Rapid spread of influenza A(H1N1)pdm09 viruses with a new set of specific mutations in the internal genes in the beginning of2015/2016 epidemic season in Moscow and Saint-Petersburg (Russian Federation) // Influenza & Other Respiratory Viruses. 2016. Vol. 10, N 4. P. 247-253.; WHO Global Influenza Surveillance Network. Manual for the laboratory diagnosis and virological surveillance of influenza. 2011. ISBN: 9789241548090.; Мatrosovich M., Matrosovich T, Carr G., et al. Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors // J. Virol. 2003. Vol. 77, N 15. P. 8418-8425.; Соминина А.А., Бурцева Е.И., Лобова Т.Г. и др. Выделение вирусов сезонного и потенциально пандемического гриппа в клеточных культурах и куриных эмбрионах и их идентификация: Метод. рекомендации (утверждены ФС по надзору в сфере защиты прав потребителей и благополучия человека от 18 апреля 2006 г. N.0100/4430-06-34). М.; 2006.; Львов Д.К., Яшкулов К.Б., Прилипов А.Г. и др. Обнаружение аминокислотных замен аспарагиновой кислоты на глицин и аспарагин в рецепторсвязывающем сайте гемагглютинина в вариантах пандемического вируса гриппа A/H1N1 от больных с летальным исходом и со среднетяжелой формой заболевания // Вопросы вирусологии. 2010. Т. 55, № 3. С. 15-28.; Leang S.K., Hurt A.C. Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals // J. Vis. Exp. 2017. Vol. 122. P. e55570.; Львов Д.К., Бурцева Е.И., Кириллова Е.С. и др. Дрейфовая изменчивость вируса гриппа A(H3N2): биологические, антигенные и генетические свойства в эпидемическом сезоне 2016-2017гг. в России и странах Северного полушария // Вопросы вирусологии. 2018. T. 63, № 2. С. 61-68.; Seasonal influenza in the WHO European Region, 2017-2018 early season (2018). Доступно по: http://www.euro.who.int/en/health-topics/communicable-diseases/influenza/publications/2018/seasonal-influenza-in-the-who-european-region,-2017-2018-early-season Ссылка активна на 8 апреля 2019.; WHO. Influenza: Surveillance and Monitoring (GISRS). Доступно по: https://www.who.int/influenza/surveillance_monitoring/en/ Ссылка активна на 8 апреля 2019.; WHO. Influenza: FluNet Summary. Доступно по: http://www.who.int/influenza/gisrs_laboratory/updates/summaryreport/en Ссылка активна на 8 апреля 2019.; CDC&P, Atlanta, USA. Weekly U.S. Influenza Surveillance Report. Доступно по: https://www.cdc.gov/flu/weekly/Ссылка активна на 8 апреля 2019.; WHO. Flu News Europe. Доступно по: http://www.flunewseurope.org/. Ссылка активна на 8 апреля 2019.; ФГБУ «НИИ гриппа им. А.А. Смородинцева» Минздрава России. Доступно по: www.influenza.spb.ru Ссылка активна на 8 апреля 2019.; WHO Consultation and Information Meeting on the Composition of Influenza Virus Vaccines for Use in the 2019-20 Northern Hemisphere Influenza Season. Доступно по: https://www.who.int/influenza/vaccines/virus/recommendations/consultation201902/en/Ссылка активна на 8 апреля 2019.; WHO. Influenza: Avian and other zoonotic influenza. Доступно по: http://www.who.int/influenza/human_animal_interface/en/ Ссылка активна на 8 апреля 2019.; WHO. Influenza: Avian influenza A(H7N9) virus. Доступно по: https://www.who.int/influenza/human_animal_interface/influenza_h7n9/en/ Ссылка активна на 8 апреля 2019.; WHO. Influenza: Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO. Доступно по: https://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/ Ссылка активна на 8 апреля 2019.; CDC&P, Atlanta, USA. Variant Influenza Viruses in Humans. Доступно по: https://www.cdc.gov/flu/swineflu/variant-flu-in-humans.htm Ссылка активна на 8 апреля 2019.; https://www.epidemvac.ru/jour/article/view/737
DOI: 10.31631/2073-3046-2019-18-3-13-21
الاتاحة: https://www.epidemvac.ru/jour/article/view/737
https://doi.org/10.31631/2073-3046-2019-18-3-13-21
Rights: Authors who publish with this journal agree to the following terms:Authors retain copyright and grant to the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors may enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). ; Авторы, публикующиеся в данном журнале, соглашаются со следующим:Авторы сохраняют за собой авторские права на работу и предоставляют журналу право первой публикации работы на условиях лицензии Creative Commons Attribution License, которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в этом журнале.Авторы сохраняют право заключать отдельные контрактные договорённости, касающиеся не-эксклюзивного распространения версии работы в опубликованном здесь виде (например, размещение ее в институтском хранилище, публикацию в книге), со ссылкой на ее оригинальную публикацию в этом журнале.Авторы имеют право размещать их работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу (См. The Effect of Open Access).
رقم الانضمام: edsbas.B8764112
قاعدة البيانات: BASE
ResultId 1
Header edsbas
BASE
edsbas.B8764112
893
3
Academic Journal
academicJournal
892.664306640625
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.B8764112&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Array ( [0] => Array ( [Url] => https://www.epidemvac.ru/jour/article/view/737# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => The Activity of Influenza Viruses during 2017-2018 Season in Russia and Countries of the Northern Hemisphere: Conflict by the B-virus Vaccine Component ; Активность вирусов гриппа в сезон 2017-2018 гг. в России и странах Северного полушария: конфликт по В-вирусному компоненту вакцин )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22D%2E+Lvov+K%2E%22">D. Lvov K.</searchLink><br /><searchLink fieldCode="AR" term="%22E%2E+Burtseva+I%2E%22">E. Burtseva I.</searchLink><br /><searchLink fieldCode="AR" term="%22E%2E+Mukasheva+A%2E%22">E. Mukasheva A.</searchLink><br /><searchLink fieldCode="AR" term="%22L%2E+Kolobukhina+V%2E%22">L. Kolobukhina V.</searchLink><br /><searchLink fieldCode="AR" term="%22S%2E+Trushakova+V%2E%22">S. Trushakova V.</searchLink><br /><searchLink fieldCode="AR" term="%22N%2E+Breslav+V%2E%22">N. Breslav V.</searchLink><br /><searchLink fieldCode="AR" term="%22E%2E+Feodoritova+L%2E%22">E. Feodoritova L.</searchLink><br /><searchLink fieldCode="AR" term="%22L%2E+Merkulova+N%2E%22">L. Merkulova N.</searchLink><br /><searchLink fieldCode="AR" term="%22K%2E+Krasnoslobotsev+G%2E%22">K. Krasnoslobotsev G.</searchLink><br /><searchLink fieldCode="AR" term="%22E%2E+Morozova+O%2E%22">E. Morozova O.</searchLink><br /><searchLink fieldCode="AR" term="%22I%2E+Fedyakina+T%2E%22">I. Fedyakina T.</searchLink><br /><searchLink fieldCode="AR" term="%22A%2E+Aristova+V%2E%22">A. Aristova V.</searchLink><br /><searchLink fieldCode="AR" term="%22R%2E+Vartanian+V%2E%22">R. Vartanian V.</searchLink><br /><searchLink fieldCode="AR" term="%22L%2E+Kisteneva+B%2E%22">L. Kisteneva B.</searchLink><br /><searchLink fieldCode="AR" term="%22A%2E+Prilipov+G%2E%22">A. Prilipov G.</searchLink><br /><searchLink fieldCode="AR" term="%22S%2E+Alkhovsky+V%2E%22">S. Alkhovsky V.</searchLink><br /><searchLink fieldCode="AR" term="%22A%2E+Rosatkevich+G%2E%22">A. Rosatkevich G.</searchLink><br /><searchLink fieldCode="AR" term="%22I%2E+Kruzhkova+S%2E%22">I. Kruzhkova S.</searchLink><br /><searchLink fieldCode="AR" term="%22A%2E+Belyaev+L%2E%22">A. Belyaev L.</searchLink><br /><searchLink fieldCode="AR" term="%22E%2E+Axselrod+V%2E%22">E. Axselrod V.</searchLink><br /><searchLink fieldCode="AR" term="%22M%2E+Bazarova+V%2E%22">M. Bazarova V.</searchLink><br /><searchLink fieldCode="AR" term="%22S%2E+Smetanina+V%2E%22">S. Smetanina V.</searchLink><br /><searchLink fieldCode="AR" term="%22Д%2E+Львов+К%2E%22">Д. Львов К.</searchLink><br /><searchLink fieldCode="AR" term="%22Е%2E+Бурцева+И%2E%22">Е. Бурцева И.</searchLink><br /><searchLink fieldCode="AR" term="%22Е%2E+Мукашева+А%2E%22">Е. Мукашева А.</searchLink><br /><searchLink fieldCode="AR" term="%22Л%2E+Колобухина+В%2E%22">Л. Колобухина В.</searchLink><br /><searchLink fieldCode="AR" term="%22С%2E+Трушакова+В%2E%22">С. Трушакова В.</searchLink><br /><searchLink fieldCode="AR" term="%22Н%2E+Бреслав+В%2E%22">Н. Бреслав В.</searchLink><br /><searchLink fieldCode="AR" term="%22Е%2E+Феодоритова+Л%2E%22">Е. Феодоритова Л.</searchLink><br /><searchLink fieldCode="AR" term="%22Л%2E+Меркулова+Н%2E%22">Л. Меркулова Н.</searchLink><br /><searchLink fieldCode="AR" term="%22К%2E+Краснослободцев+Г%2E%22">К. Краснослободцев Г.</searchLink><br /><searchLink fieldCode="AR" term="%22Е%2E+Морозова+О%2E%22">Е. Морозова О.</searchLink><br /><searchLink fieldCode="AR" term="%22И%2E+Федякина+Т%2E%22">И. Федякина Т.</searchLink><br /><searchLink fieldCode="AR" term="%22В%2E+Аристова+А%2E%22">В. Аристова А.</searchLink><br /><searchLink fieldCode="AR" term="%22Р%2E+Вартанян+В%2E%22">Р. Вартанян В.</searchLink><br /><searchLink fieldCode="AR" term="%22Л%2E+Кистенева+Б%2E%22">Л. Кистенева Б.</searchLink><br /><searchLink fieldCode="AR" term="%22А%2E+Прилипов+Г%2E%22">А. Прилипов Г.</searchLink><br /><searchLink fieldCode="AR" term="%22С%2E+Альховский+В%2E%22">С. Альховский В.</searchLink><br /><searchLink fieldCode="AR" term="%22А%2E+Росаткевич+Г%2E%22">А. Росаткевич Г.</searchLink><br /><searchLink fieldCode="AR" term="%22И%2E+Кружкова+С%2E%22">И. Кружкова С.</searchLink><br /><searchLink fieldCode="AR" term="%22А%2E+Беляев+Л%2E%22">А. Беляев Л.</searchLink><br /><searchLink fieldCode="AR" term="%22Э%2E+Аксельрод+В%2E%22">Э. Аксельрод В.</searchLink><br /><searchLink fieldCode="AR" term="%22М%2E+Базарова+В%2E%22">М. Базарова В.</searchLink><br /><searchLink fieldCode="AR" term="%22С%2E+Сметанина+В%2E%22">С. Сметанина В.</searchLink> )
Array ( [Name] => Author [Label] => Contributors [Group] => Au [Data] => The work was supported by the Cooperative agreement «The support of potential for influenza surveillance in Russia» with Centers for Disease Control and Prevention, Atlanta, USA<br />Исследование было частично поддержано Кооперативным cоглашением «Поддержание потенциала по надзору за гриппом в России» с Центрами по контролю и профилактике заболеваний, Атланта, США )
Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Epidemiology and Vaccinal Prevention; Том 18, № 3 (2019); 13-21 ; Эпидемиология и Вакцинопрофилактика; Том 18, № 3 (2019); 13-21 ; 2619-0494 ; 2073-3046 ; 10.31631/2073-3046-2019-18-3 )
Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => «Numicom» LLC )
Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2019 )
Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => Epidemiology and Vaccine Prevention (E-Journal) / Эпидемиология и Вакцинопрофилактика )
Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22epidemic+season+2017-2018%22">epidemic season 2017-2018</searchLink><br /><searchLink fieldCode="DE" term="%22influenza+viruses%22">influenza viruses</searchLink><br /><searchLink fieldCode="DE" term="%22antigenic+properties%22">antigenic properties</searchLink><br /><searchLink fieldCode="DE" term="%22genetic+properties%22">genetic properties</searchLink><br /><searchLink fieldCode="DE" term="%22sensitivity+to+neuraminidase+inhibitors%22">sensitivity to neuraminidase inhibitors</searchLink><br /><searchLink fieldCode="DE" term="%22recommendations+for+influenza+vaccines+composition+in+the+season+2019-2020%22">recommendations for influenza vaccines composition in the season 2019-2020</searchLink><br /><searchLink fieldCode="DE" term="%22эпидемический+сезон+2017-2018%22">эпидемический сезон 2017-2018</searchLink><br /><searchLink fieldCode="DE" term="%22вирусы+гриппа%22">вирусы гриппа</searchLink><br /><searchLink fieldCode="DE" term="%22антигенные+свойства%22">антигенные свойства</searchLink><br /><searchLink fieldCode="DE" term="%22генетические+свойства%22">генетические свойства</searchLink><br /><searchLink fieldCode="DE" term="%22чувствительность+к+антинейраминидазным+препаратам%22">чувствительность к антинейраминидазным препаратам</searchLink><br /><searchLink fieldCode="DE" term="%22рекомендации+по+составу+гриппозных+вакцин+в+сезоне+2019-2020+гг%22">рекомендации по составу гриппозных вакцин в сезоне 2019-2020 гг</searchLink> )
Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Relevance. Influenza viruses, having an extremely high variability of the genome and significant environmental plasticity, continue to maintain a potential threat to the biological safety of mankind. The purpose Aims of the work is to analyze the features of the epidemic season of2017-2018.Materials and methods. The collection of data on the incidence and laboratory diagnosis of influenza and ARVI was carried out in the framework of the epidemiological surveillance of the circulation of influenza viruses in the Russian Federation. The observation period was from 40 weeks (october) 2017 to 25 weeks (june) 2018. The typing of the isolates was performed in the reaction of inhibition of hemagglutination activity (HI) according to the standard technique with diagnostic sera to reference and epidemic influenza viruses.Results and discussion. The article presents the features of the influenza virus circulation n for the period from october 2017 to may 2018 in some territories of Russia, collaborating with D. I. Ivanovsky Institute of Virology. The epidemic season had its own peculiarities: delayed and long-term activity of three influenza viruses, the share participation of which was almost equal, with some dominance of the influenza A(H1N1)pdm09 virus by the end of the season. Morbidity rates for the total population were comparable with the last epidemic season, meantime the morbidity among schoolchildren was higher. The number of hospitalizations and lethal outcomes was lower and mostly was found in patients of 65 years and older. In patients with severe acute respiratory infection (SARI) influenza A(H1N1)pdm09 was detected more frequently (58%). The influenza A(H1N1)pdm09 and A(H3N2) viruses were antigenically similar to strains included in influenza vaccines, at the same time, 96% of the isolated strains of influenza B virus belonged to a different evolutionary line. Epidemic strains were sensitive to neuraminidase inhibitors, except for 5 strains of influenza A(H1N1)pdm09 virus, isolated from pregnant ... )
Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper )
Array ( [Name] => Format [Label] => File Description [Group] => SrcInfo [Data] => application/pdf )
Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => Russian )
Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => https://www.epidemvac.ru/jour/article/view/737/537; Komissarov A., Fadeev A., Petrov S., et al. Rapid spread of influenza A(H1N1)pdm09 viruses with a new set of specific mutations in the internal genes in the beginning of2015/2016 epidemic season in Moscow and Saint-Petersburg (Russian Federation) // Influenza & Other Respiratory Viruses. 2016. Vol. 10, N 4. P. 247-253.; WHO Global Influenza Surveillance Network. Manual for the laboratory diagnosis and virological surveillance of influenza. 2011. ISBN: 9789241548090.; Мatrosovich M., Matrosovich T, Carr G., et al. Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors // J. Virol. 2003. Vol. 77, N 15. P. 8418-8425.; Соминина А.А., Бурцева Е.И., Лобова Т.Г. и др. Выделение вирусов сезонного и потенциально пандемического гриппа в клеточных культурах и куриных эмбрионах и их идентификация: Метод. рекомендации (утверждены ФС по надзору в сфере защиты прав потребителей и благополучия человека от 18 апреля 2006 г. N.0100/4430-06-34). М.; 2006.; Львов Д.К., Яшкулов К.Б., Прилипов А.Г. и др. Обнаружение аминокислотных замен аспарагиновой кислоты на глицин и аспарагин в рецепторсвязывающем сайте гемагглютинина в вариантах пандемического вируса гриппа A/H1N1 от больных с летальным исходом и со среднетяжелой формой заболевания // Вопросы вирусологии. 2010. Т. 55, № 3. С. 15-28.; Leang S.K., Hurt A.C. Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals // J. Vis. Exp. 2017. Vol. 122. P. e55570.; Львов Д.К., Бурцева Е.И., Кириллова Е.С. и др. Дрейфовая изменчивость вируса гриппа A(H3N2): биологические, антигенные и генетические свойства в эпидемическом сезоне 2016-2017гг. в России и странах Северного полушария // Вопросы вирусологии. 2018. T. 63, № 2. С. 61-68.; Seasonal influenza in the WHO European Region, 2017-2018 early season (2018). Доступно по: http://www.euro.who.int/en/health-topics/communicable-diseases/influenza/publications/2018/seasonal-influenza-in-the-who-european-region,-2017-2018-early-season Ссылка активна на 8 апреля 2019.; WHO. Influenza: Surveillance and Monitoring (GISRS). Доступно по: https://www.who.int/influenza/surveillance_monitoring/en/ Ссылка активна на 8 апреля 2019.; WHO. Influenza: FluNet Summary. Доступно по: http://www.who.int/influenza/gisrs_laboratory/updates/summaryreport/en Ссылка активна на 8 апреля 2019.; CDC&P, Atlanta, USA. Weekly U.S. Influenza Surveillance Report. Доступно по: https://www.cdc.gov/flu/weekly/Ссылка активна на 8 апреля 2019.; WHO. Flu News Europe. Доступно по: http://www.flunewseurope.org/. Ссылка активна на 8 апреля 2019.; ФГБУ «НИИ гриппа им. А.А. Смородинцева» Минздрава России. Доступно по: www.influenza.spb.ru Ссылка активна на 8 апреля 2019.; WHO Consultation and Information Meeting on the Composition of Influenza Virus Vaccines for Use in the 2019-20 Northern Hemisphere Influenza Season. Доступно по: https://www.who.int/influenza/vaccines/virus/recommendations/consultation201902/en/Ссылка активна на 8 апреля 2019.; WHO. Influenza: Avian and other zoonotic influenza. Доступно по: http://www.who.int/influenza/human_animal_interface/en/ Ссылка активна на 8 апреля 2019.; WHO. Influenza: Avian influenza A(H7N9) virus. Доступно по: https://www.who.int/influenza/human_animal_interface/influenza_h7n9/en/ Ссылка активна на 8 апреля 2019.; WHO. Influenza: Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO. Доступно по: https://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/ Ссылка активна на 8 апреля 2019.; CDC&P, Atlanta, USA. Variant Influenza Viruses in Humans. Доступно по: https://www.cdc.gov/flu/swineflu/variant-flu-in-humans.htm Ссылка активна на 8 апреля 2019.; https://www.epidemvac.ru/jour/article/view/737 )
Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.31631/2073-3046-2019-18-3-13-21 )
Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://www.epidemvac.ru/jour/article/view/737<br />https://doi.org/10.31631/2073-3046-2019-18-3-13-21 )
Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => Authors who publish with this journal agree to the following terms:Authors retain copyright and grant to the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors may enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). ; Авторы, публикующиеся в данном журнале, соглашаются со следующим:Авторы сохраняют за собой авторские права на работу и предоставляют журналу право первой публикации работы на условиях лицензии Creative Commons Attribution License, которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в этом журнале.Авторы сохраняют право заключать отдельные контрактные договорённости, касающиеся не-эксклюзивного распространения версии работы в опубликованном здесь виде (например, размещение ее в институтском хранилище, публикацию в книге), со ссылкой на ее оригинальную публикацию в этом журнале.Авторы имеют право размещать их работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу (См. The Effect of Open Access). )
Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.B8764112 )
RecordInfo Array ( [BibEntity] => Array ( [Identifiers] => Array ( [0] => Array ( [Type] => doi [Value] => 10.31631/2073-3046-2019-18-3-13-21 ) ) [Languages] => Array ( [0] => Array ( [Text] => Russian ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => epidemic season 2017-2018 [Type] => general ) [1] => Array ( [SubjectFull] => influenza viruses [Type] => general ) [2] => Array ( [SubjectFull] => antigenic properties [Type] => general ) [3] => Array ( [SubjectFull] => genetic properties [Type] => general ) [4] => Array ( [SubjectFull] => sensitivity to neuraminidase inhibitors [Type] => general ) [5] => Array ( [SubjectFull] => recommendations for influenza vaccines composition in the season 2019-2020 [Type] => general ) [6] => Array ( [SubjectFull] => эпидемический сезон 2017-2018 [Type] => general ) [7] => Array ( [SubjectFull] => вирусы гриппа [Type] => general ) [8] => Array ( [SubjectFull] => антигенные свойства [Type] => general ) [9] => Array ( [SubjectFull] => генетические свойства [Type] => general ) [10] => Array ( [SubjectFull] => чувствительность к антинейраминидазным препаратам [Type] => general ) [11] => Array ( [SubjectFull] => рекомендации по составу гриппозных вакцин в сезоне 2019-2020 гг [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => The Activity of Influenza Viruses during 2017-2018 Season in Russia and Countries of the Northern Hemisphere: Conflict by the B-virus Vaccine Component ; Активность вирусов гриппа в сезон 2017-2018 гг. в России и странах Северного полушария: конфликт по В-вирусному компоненту вакцин [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => D. Lvov K. ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => E. Burtseva I. ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => E. Mukasheva A. ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => L. Kolobukhina V. ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => S. Trushakova V. ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => N. Breslav V. ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => E. Feodoritova L. ) ) ) [7] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => L. Merkulova N. ) ) ) [8] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => K. Krasnoslobotsev G. ) ) ) [9] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => E. Morozova O. ) ) ) [10] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => I. Fedyakina T. ) ) ) [11] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => A. Aristova V. ) ) ) [12] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => R. Vartanian V. ) ) ) [13] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => L. Kisteneva B. ) ) ) [14] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => A. Prilipov G. ) ) ) [15] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => S. Alkhovsky V. ) ) ) [16] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => A. Rosatkevich G. ) ) ) [17] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => I. Kruzhkova S. ) ) ) [18] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => A. Belyaev L. ) ) ) [19] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => E. Axselrod V. ) ) ) [20] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => M. Bazarova V. ) ) ) [21] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => S. Smetanina V. ) ) ) [22] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Д. Львов К. ) ) ) [23] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Е. Бурцева И. ) ) ) [24] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Е. Мукашева А. ) ) ) [25] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Л. Колобухина В. ) ) ) [26] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => С. Трушакова В. ) ) ) [27] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Н. Бреслав В. ) ) ) [28] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Е. Феодоритова Л. ) ) ) [29] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Л. Меркулова Н. ) ) ) [30] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => К. Краснослободцев Г. ) ) ) [31] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Е. Морозова О. ) ) ) [32] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => И. Федякина Т. ) ) ) [33] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => В. Аристова А. ) ) ) [34] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Р. Вартанян В. ) ) ) [35] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Л. Кистенева Б. ) ) ) [36] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => А. Прилипов Г. ) ) ) [37] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => С. Альховский В. ) ) ) [38] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => А. Росаткевич Г. ) ) ) [39] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => И. Кружкова С. ) ) ) [40] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => А. Беляев Л. ) ) ) [41] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Э. Аксельрод В. ) ) ) [42] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => М. Базарова В. ) ) ) [43] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => С. Сметанина В. ) ) ) [44] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => The work was supported by the Cooperative agreement «The support of potential for influenza surveillance in Russia» with Centers for Disease Control and Prevention, Atlanta, USA ) ) ) [45] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Исследование было частично поддержано Кооперативным cоглашением «Поддержание потенциала по надзору за гриппом в России» с Центрами по контролю и профилактике заболеваний, Атланта, США ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 01 [Type] => published [Y] => 2019 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-locals [Value] => edsbas ) [1] => Array ( [Type] => issn-locals [Value] => edsbas.oa ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Epidemiology and Vaccinal Prevention; Том 18, № 3 (2019); 13-21 ; Эпидемиология и Вакцинопрофилактика; Том 18, № 3 (2019); 13-21 ; 2619-0494 ; 2073-3046 ; 10.31631/2073-3046-2019-18-3 [Type] => main ) ) ) ) ) ) )
IllustrationInfo